Physician profile
James E Mullins
NPI 1871597518
$1,094.16
in general payments reported to CMS, 2019-2025
23 companies · $93.34 in 2025
The $93.34 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $228 · 2021: $147 · 2022: $56.93 · 2023: $24.39 · 2024: $313 · 2025: $93.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255 · Education: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.71 |
| Education | $175.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $198.25 | 2024 | Veozah |
| Abbvie INC. | $162.17 | 2019-2021 | |
| Minerva Surgical, INC | $92.01 | 2024 | |
| Aspira Women'S Health INC | $91.32 | 2020-2021 | |
| Medtronic, INC. | $79.20 | 2022-2025 | Truclear |
| Mylan Pharmaceuticals INC. | $45.60 | 2020-2021 | |
| Exeltis, USA INC. | $42.34 | 2020 | |
| Avion Pharmaceuticals | $37.98 | 2020 | |
| Gynesonics, INC. | $37.38 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $37.14 | 2019-2020 | |
| Pfizer INC. | $34.32 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.67 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $31.65 | 2025 | |
| Biogen, INC. | $26.43 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $24.69 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $22.81 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.40 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.05 | 2020 | |
| Coopersurgical, INC. | $14.03 | 2019 | |
| Daiichi Sankyo INC. | $13.91 | 2020 | |
| Mayne Pharma Commercial LLC | $13.59 | 2021 | |
| Acessa Health INC. | $11.28 | 2019 | |
| Lupin INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mullins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.